Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
trial safety data
Biotech
Kezar suspends key lupus study after 4 deaths
The voluntary hold comes after Kezar restructured last year to in a bid to support its lupus and hepatitis candidate zetomipzomib.
Zoey Becker
Sep 30, 2024 11:23am
WCG Clinical rolls out safety management product for biopharmas
Jan 31, 2022 3:15pm
AstraZeneca's COVID-19 vaccine hold sparks reassessment of race
Sep 9, 2020 4:07am
Bioclinica names new CEO, launches clinical adjudication
Dec 5, 2017 5:04am
DBV climbs as peanut allergy safety data come in clean
Nov 20, 2017 9:30am
Theravance COPD drug clears safety study, setting up NDA
Jul 20, 2017 6:44am
